Lung Cancer Episode 3: Adjuvant Pembrolizumab for Early-Stage NSCLC After Resection and Optional Chemotherapy: the PEARLS trial 13 February 2024
Lung Cancer Episode 1: IMpower010, first data on OS in first line treatment with azetolizumab in NSCLC patients 30 January 2024
Breast Cancer Episode 12: Antibody-drug conjugates: the evolving field of targeted chemotherapy in breast cancer 21 December 2023
